Status:
COMPLETED
Post Marketing Surveillance Study on Emselex After Launch in Germany
Lead Sponsor:
Bayer
Conditions:
Overactive Bladder
Eligibility:
All Genders
18+ years
Brief Summary
\- Data are obtained of Emselex in routine treatment of Overactive Bladder. The general objectives are to evaluate the product safety, compatibility, efficacy and patient acceptance.
Eligibility Criteria
Inclusion
- Patients who are treated with Emselex for Overactive Bladder
Exclusion
- Exclusion criteria are the contraindications as specified in the German product information
Key Trial Info
Start Date :
January 1 2005
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 1 2006
Estimated Enrollment :
5821 Patients enrolled
Trial Details
Trial ID
NCT00786448
Start Date
January 1 2005
End Date
February 1 2006
Last Update
April 30 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Many Locations, Germany